These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25552303)

  • 1. Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.
    Ravenscroft G; Laing NG; Bönnemann CG
    Brain; 2015 Feb; 138(Pt 2):246-68. PubMed ID: 25552303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.
    Jungbluth H; Treves S; Zorzato F; Sarkozy A; Ochala J; Sewry C; Phadke R; Gautel M; Muntoni F
    Nat Rev Neurol; 2018 Mar; 14(3):151-167. PubMed ID: 29391587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital myopathies and related disorders.
    Taratuto AL
    Curr Opin Neurol; 2002 Oct; 15(5):553-61. PubMed ID: 12351999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Congenital Myopathies in Adulthood.
    Papadimas GK; Xirou S; Kararizou E; Papadopoulos C
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathology in congenital myopathies.
    Sewry CA; Wallgren-Pettersson C
    Neuropathol Appl Neurobiol; 2017 Feb; 43(1):5-23. PubMed ID: 27976420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centronuclear myopathies under attack: A plethora of therapeutic targets.
    Tasfaout H; Cowling BS; Laporte J
    J Neuromuscul Dis; 2018; 5(4):387-406. PubMed ID: 30103348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New era in genetics of early-onset muscle disease: Breakthroughs and challenges.
    Ravenscroft G; Davis MR; Lamont P; Forrest A; Laing NG
    Semin Cell Dev Biol; 2017 Apr; 64():160-170. PubMed ID: 27519468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Congenital Myopathies.
    Mah JK; Joseph JT
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1932-1953. PubMed ID: 27922501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in neuromuscular disorders? The congenital myopathies.
    Jungbluth H; Sewry CA; Muntoni F
    Eur J Paediatr Neurol; 2003; 7(1):23-30. PubMed ID: 12615171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical approach to the diagnosis of congenital myopathies.
    North KN
    Semin Pediatr Neurol; 2011 Dec; 18(4):216-20. PubMed ID: 22172416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of congenital myopathies.
    Gonorazky HD; Bönnemann CG; Dowling JJ
    Handb Clin Neurol; 2018; 148():549-564. PubMed ID: 29478600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibrillar myopathies: State of the art, present and future challenges.
    Béhin A; Salort-Campana E; Wahbi K; Richard P; Carlier RY; Carlier P; Laforêt P; Stojkovic T; Maisonobe T; Verschueren A; Franques J; Attarian S; Maues de Paula A; Figarella-Branger D; Bécane HM; Nelson I; Duboc D; Bonne G; Vicart P; Udd B; Romero N; Pouget J; Eymard B
    Rev Neurol (Paris); 2015 Oct; 171(10):715-29. PubMed ID: 26342832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial abnormalities in the myofibrillar myopathies.
    Jackson S; Schaefer J; Meinhardt M; Reichmann H
    Eur J Neurol; 2015 Nov; 22(11):1429-35. PubMed ID: 26204918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Genetics of Congenital Myopathies.
    Pelin K; Wallgren-Pettersson C
    Semin Pediatr Neurol; 2019 Apr; 29():12-22. PubMed ID: 31060721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital myopathies].
    Cabello A; Ricoy-Campo JR
    Rev Neurol; 2003 Oct 16-31; 37(8):779-86. PubMed ID: 14593641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myofibrillar myopathies].
    Olivé-Plana M
    Rev Neurol; 2003 Oct 16-31; 37(8):770-2. PubMed ID: 14593638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Aspects in Congenital Myopathies.
    Jungbluth H; Muntoni F
    Semin Pediatr Neurol; 2019 Apr; 29():71-82. PubMed ID: 31060727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Structural Defects in Canine Centronuclear Myopathy Indicate a Role for HACD1 in Maintaining Skeletal Muscle Membrane Systems.
    Walmsley GL; Blot S; Venner K; Sewry C; Laporte J; Blondelle J; Barthélémy I; Maurer M; Blanchard-Gutton N; Pilot-Storck F; Tiret L; Piercy RJ
    Am J Pathol; 2017 Feb; 187(2):441-456. PubMed ID: 27939133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.